Zobrazeno 1 - 10
of 87
pro vyhledávání: ''
Publikováno v:
British Journal of Cancer. 3/12/2007, Vol. 96 Issue 5, p744-751. 8p. 1 Diagram, 2 Charts.
Publikováno v:
British Journal of Cancer. 1/17/2005, Vol. 92 Issue 1, p47-54. 8p.
Publikováno v:
Cancer Gene Therapy. Sep2004, Vol. 11 Issue 9, p594-602. 9p.
Autor:
Sainsbury, R.1 r.sainsbury@ucl.ac.uk
Publikováno v:
British Journal of Cancer. 5/4/2004, Vol. 90 Issue 9, p1733-1739. 7p.
Publikováno v:
Calcified Tissue International; Feb2018, Vol. 102 Issue 2, p251-264, 14p
Autor:
Browall, Maria, Brandberg, Yvonne, Nasic, Salmir, Rydberg, Per, Bergh, Jonas, Rydén, Andreas, Xie, Hanjing, Eriksson, Irene, Wengström, Yvonne, Rydén, Andreas, Wengström, Yvonne
Publikováno v:
Supportive Care in Cancer; May2017, Vol. 25 Issue 5, p1423-1429, 7p
Autor:
Wells, Kristen, Pan, Tonya, Vázquez-Otero, Coralia, Ung, Danielle, Ustjanauskas, Amy, Muñoz, Dariana, Laronga, Christine, Roetzheim, Richard, Goldenstein, Marissa, Carrizosa, Claudia, Nuhaily, Sumayah, Johnson, Kenneth, Norton, Marilyn, Sims, Elizabeth, Quinn, Gwendolyn, Wells, Kristen J, Pan, Tonya M, Ustjanauskas, Amy E, Roetzheim, Richard G, Quinn, Gwendolyn P
Publikováno v:
Supportive Care in Cancer; Oct2016, Vol. 24 Issue 10, p4123-4130, 8p
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
© The Japanese Breast Cancer Society 2020
Circular RNAs are a large group of non-coding RNAs with a closed-loop structure. circRNAs play significant roles in many biological processes as miRNA sponges, regulators for gene transcription, combini
Circular RNAs are a large group of non-coding RNAs with a closed-loop structure. circRNAs play significant roles in many biological processes as miRNA sponges, regulators for gene transcription, combini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::801707b328990305344fcc66688ff574
https://hdl.handle.net/10451/49737
https://hdl.handle.net/10451/49737
Autor:
Masako Sato, Hidetoshi Kawaguchi, Satoshi Morita, Makiko Mizutani, Yoshie Hasegawa, Ken-ichi Watanabe, Yasuaki Sagara, Fumikata Hara, Takashi Morimoto, Takahiro Nakayama, Norikazu Masuda, Mitsuya Itoh, Shoichiro Ohtani, Nobuki Matsunami, Kenji Higaki, Masato Takahashi, Tetsuhiro Yoshinami
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background This study aimed to investigate whether schedule modification is safe and effective in patients intolerant to the standard eribulin dose and schedule. Methods Patients with metastatic breast cancer (MBC) treated with both anthracycline and
Autor:
Njiaju, U., Tevaarwerk, A., Kim, K., Chang, J., Hansen, R., Champeny, T., Traynor, A., Meadows, S., Ummersen, L., Powers, K., Stewart, J.
Publikováno v:
Cancer Chemotherapy & Pharmacology; Mar2013, Vol. 71 Issue 3, p613-618, 6p